Chili peppers, nerve regeneration, and clinical trial design

Authors:

Abstract
One challenge for testing therapeutic approaches is the limited ability of currently available primary outcome measures such as clinical impairment scales and nerve conduction studies to document functional changes in small caliber sensory nerve fibers that are involved early in SN.4 A consequence is that subjects with relatively advanced SN are the focus of clinical trials. Furthermore, as the common forms of SN progress slowly, conventional outcome measures require lengthy studies (on the order of years) to demonstrate efficacy for slowing of progression.5